The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1356
ISSUE1356
January 24, 2011
Botulinum Toxin for Chronic Migraine
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Botulinum Toxin for Chronic Migraine
January 24, 2011 (Issue: 1356)
The FDA has approved injection of onabotulinumtoxinA
(Botox – Allergan) for prevention of
headaches in adult patients with chronic migraine (≥15
headache days/month for ≥3 months). It is the first
drug approved for treatment of this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.